Skip to main
LQDA

LQDA Stock Forecast & Price Target

LQDA Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 13%
Hold 25%
Sell 13%
Strong Sell 0%

Bulls say

Liquidia is demonstrating strong growth momentum, with sales annualizing at around $682 million and a significant market share increase of 30% in the 2nd quarter of 2026. The company's financials show increasing profitability and positive cash flow, with cash reserves of $284.2 million as of the end of 2nd quarter of 2026. Looking ahead, the company's strategic expansion of its development pipeline and sales force, as well as its focus on inhaled dry powder delivery technology, positions it well for continued success in the treatment of pulmonary hypertension.

Bears say

Liquidia is positioned to capitalize on the growing market for pulmonary hypertension treatment with its lead candidate Yutrepia, but faces potential legal risks with ongoing patent lawsuits and competition from novel therapies. However, the company has shown strong growth in key metrics and a strong pipeline, though its dependence on a single product could pose a risk to future financial performance. Monitoring legal developments and market adoption will be key for evaluating the company's future prospects.

LQDA has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 13% recommend Buy, 25% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Liquidia Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Liquidia Technologies Inc (LQDA) Forecast

Analysts have given LQDA a Buy based on their latest research and market trends.

According to 8 analysts, LQDA has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Liquidia Technologies Inc (LQDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.